A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
FindCure Biosciences (ZhongShan) Co., Ltd.
Genmab
West China Hospital
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
FindCure Biosciences (ZhongShan) Co., Ltd.
Moon (Guangzhou) Biotechnology Co., Ltd.
The First Affiliated Hospital of Nanchang University
Shanghai Junshi Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
Hutchmed
Stemirna Therapeutics
Shanghai Miracogen Inc.
AnewPharma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Hutchmed
AnewPharma
Tasly Tianjin Biopharmaceutical Co., Ltd.
AnewPharma
Takeda
Puma Biotechnology, Inc.
Puma Biotechnology, Inc.
Wyeth is now a wholly owned subsidiary of Pfizer
Puma Biotechnology, Inc.
Pfizer
Fudan University